×
About 699 results

ALLMedicine™ Cardiogenic Pulmonary Edema Center

Research & Reviews  335 results

Sodium coupled neutral amino acid transporter SNAT2 counteracts cardiogenic pulmonary e...
https://doi.org/10.1152/ajplung.00461.2020
American Journal of Physiology. Lung Cellular and Molecul... Weidenfeld S, Chupin C et. al.

Jan 13th, 2021 - The constant transport of ions across the alveolar epithelial barrier regulates alveolar fluid homeostasis. Dysregulation or inhibition of Na+ transport causes fluid accumulation in the distal airspaces resulting in impaired gas exchange and respi...

Nicardipine: When high dose nitrates fail in treating heart failure.
https://doi.org/10.1016/j.ajem.2020.12.016
The American Journal of Emergency Medicine; Raggi JR, O'Connell TW et. al.

Dec 28th, 2020 - Sympathetic Crashing Acute Pulmonary Edema (SCAPE) describes patients who present with acute hypertensive cardiogenic pulmonary edema. These patients present in respiratory distress, and requiring immediate medical and airway management. The treat...

Phenotypes and personalized medicine in the acute respiratory distress syndrome.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673253
Intensive Care Medicine; Matthay MA, Arabi YM et. al.

Nov 18th, 2020 - Although the acute respiratory distress syndrome (ARDS) is well defined by the development of acute hypoxemia, bilateral infiltrates and non-cardiogenic pulmonary edema, ARDS is heterogeneous in terms of clinical risk factors, physiology of lung i...

Guanfacine toxic ingestion with subsequent cardiogenic pulmonary edema.
https://doi.org/10.1016/j.ajem.2020.06.080
The American Journal of Emergency Medicine; Bridwell RE, Larson NP et. al.

Oct 18th, 2020 - Guanfacine is a central alpha-2 agonist often prescribed for Attention-deficit hyperactive disorder as well as tic disorder, with a usual dose of 1-4 mg per day. Due to its sympatholytic mechanism of action, Guanfacine can cause autonomic instabil...

see more →

Clinicaltrials.gov  351 results

Sodium coupled neutral amino acid transporter SNAT2 counteracts cardiogenic pulmonary e...
https://doi.org/10.1152/ajplung.00461.2020
American Journal of Physiology. Lung Cellular and Molecul... Weidenfeld S, Chupin C et. al.

Jan 13th, 2021 - The constant transport of ions across the alveolar epithelial barrier regulates alveolar fluid homeostasis. Dysregulation or inhibition of Na+ transport causes fluid accumulation in the distal airspaces resulting in impaired gas exchange and respi...

Nicardipine: When high dose nitrates fail in treating heart failure.
https://doi.org/10.1016/j.ajem.2020.12.016
The American Journal of Emergency Medicine; Raggi JR, O'Connell TW et. al.

Dec 28th, 2020 - Sympathetic Crashing Acute Pulmonary Edema (SCAPE) describes patients who present with acute hypertensive cardiogenic pulmonary edema. These patients present in respiratory distress, and requiring immediate medical and airway management. The treat...

Phenotypes and personalized medicine in the acute respiratory distress syndrome.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673253
Intensive Care Medicine; Matthay MA, Arabi YM et. al.

Nov 18th, 2020 - Although the acute respiratory distress syndrome (ARDS) is well defined by the development of acute hypoxemia, bilateral infiltrates and non-cardiogenic pulmonary edema, ARDS is heterogeneous in terms of clinical risk factors, physiology of lung i...

Guanfacine toxic ingestion with subsequent cardiogenic pulmonary edema.
https://doi.org/10.1016/j.ajem.2020.06.080
The American Journal of Emergency Medicine; Bridwell RE, Larson NP et. al.

Oct 18th, 2020 - Guanfacine is a central alpha-2 agonist often prescribed for Attention-deficit hyperactive disorder as well as tic disorder, with a usual dose of 1-4 mg per day. Due to its sympatholytic mechanism of action, Guanfacine can cause autonomic instabil...

see more →

News  13 results

Early Norepinephrine Stabilizes Septic Shock Patients Faster
https://www.medpagetoday.com/criticalcare/sepsis/77787

Feb 1st, 2019 - The early use of norepinephrine in patients with septic shock was associated with increased shock control within 6 hours of diagnosis in a randomized, placebo-controlled trial conducted in Thailand. Patients treated with early norepinephrine in th...

Early Norepinephrine Stabilizes Septic Shock Patients Faster
https://www.medpagetoday.com/criticalcare/sepsis/77787?comment=true

Feb 1st, 2019 - The early use of norepinephrine in patients with septic shock was associated with increased shock control within 6 hours of diagnosis in a randomized, placebo-controlled trial conducted in Thailand. Patients treated with early norepinephrine in th...

Managing Ventilation in Acute Cardiogenic Pulmonary Edema
https://www.medscape.com/viewarticle/577955

Aug 13th, 2008 - Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema Gray A, Goodacre S, Newby DE, Masson M, Sampson F, Nicholl J N Engl J Med. 2008;359:142-151 Respiratory compromise may develop in patients with cardiogenic pulmonary edema (CPE) or these...

Noninvasive Ventilation in Cardiogenic Pulmonary Edema Shows No Survival Benefit
https://www.medpagetoday.com/cardiology/acutecoronarysyndrome/10068

Jul 9th, 2008 - Action Points Explain to patients who ask that noninvasive ventilation for patients with cardiogenic pulmonary edema relieved breathing distress and avoided tracheal intubation, but did not improve survival. EDINBURGH, Scotland, July 9 -- Noninvas...

Noninvasive Ventilation Bests Oxygen for Acute Symptoms
https://www.mdedge.com/cardiology/article/41721/acute-coronary-syndromes/noninvasive-ventilation-bests-oxygen-acute
Mary Ann Moon

Both continuous positive airway pressure (CPAP) and noninvasive intermittent positive-pressure ventilation (NIPPV) yield earlier resolution of dyspnea, respiratory distress, and metabolic abnormalities than does standard oxygen therapy in patients.

see more →